AlphaMol and OncoCross made collaborations on orphan GPCR drug discovery GPCR. It combines artificial intelligence and clinical data together to advance new drug discovery for intractable diseases.
Read more
AlphaMol attended BioEuro 2022 in Leipzig, Germany and made collaborations with different partners.
Read more
The cofounders of AlphaMol Dr. Horst Vogel and Dr. Shuguang Yuan are among World’s Top 2% Scientists in the 2022 list.
Read more
AlphaMol presented in the international GPCR conference
Read more
The XXVIII Symposium on "Bioinformatics and Computer-Aided Drug Discovery--Emerging Challenges and Opportunities for In Silico Drug Discovery " was held online on May 24 - 26.
Read more
AlphaMol scientists developed a new computational algorithm for physical property predictions.
Read more
AlphaMol Science made breakthrough in orphan GPCR new drug discovery via innovative computational methods.
Read more
AlphaMol Science has obtained the top outstanding award from NVIDIA Inception contest program.
Read more
Welcome to the New website of AlphaMol Science Ltd.
Read more